Wednesday, September 16, 2026Latest filing Sep 14, 2026

Suzan K. DelBene Periodic Transaction Report

Filed Apr 10, 2025 · House Clerk · 22 transactions

U.S. Representative · D · WA-01 · All trades by Suzan K. DelBene

On April 10, 2025, Rep. Suzan K. DelBene (D-WA-01) filed a periodic transaction report with the House Clerk disclosing 22 transactions (22 sales) dated Mar 19, 2025.

None of the reported assets carry a stock ticker (bonds, funds, or private holdings).

Reported amount ranges sum to $4.1M–$8.6M. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 22 days.

22 transactions were reported under a spouse, dependent child, or joint account rather than the member directly.

Source document: House Clerk filing 20029070

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Suzan K. DelBene · Sold · Mar 19 · $250K–$500K

0.63MED
Disclosure speedx 0.250.30
Trade sizex 0.251.00
Cluster activityx 0.150.00
Track recordx 0.350.86

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Suzan K. DelBene

Get an email the moment Suzan K. DelBene files the next one. Free, no card, no spam.

Follow free →
22
Transactions
0 / 22
Buys / sells
0
Tickers
22d
Longest lag

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Mar 19, 2025Arizona Indl Dev Auth Rev BDS Lincoln 5.00% Due Nov 1, 2029 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Colorado Health Fac 5% Hosp HLTH Due 08/01/49 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Florida Dev Fin Corp Healthcare Facs Rev 4.00% Due Nov 15, 2035 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Florida HSG Fin Corp Homeowner MTG Rev 2.15% Due Jul 1, 2029 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Honolulu HI City & 4% Go Utx Due 10/01/32 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Illinois ST Sales Tax Rev JR Oblig 4.00% Due Jun 15, 2030 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Michigan ST HSG Dev Auth Single Family 1.25% Due Jun 1, 2027 [GS]sellJoint$250K–$500K22d
Mar 19, 2025New Jersey ST Transn TR FD Auth SYS BDS 5.00% Due Jun 15, 2035 [GS]sellJoint$250K–$500K22d
Mar 19, 2025New York New Y CI 2.6% Mult HSG Due 05/01/26 [GS]sellJoint$250K–$500K22d
Mar 19, 2025New York NY City Transitional Fin 5.00% Due Nov 1, 2027 [GS]sellJoint$100K–$250K22d
Mar 19, 2025New York NY City Transitional Fin 5.00% Due Feb 1, 2032 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Ohio ST Higher Ed Go BDS Ser. 2025 A 5.00% Due May 1, 2036 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Oklahoma City Okla Go BDS Ser. 2023 4.00% Due Mar 1, 2035 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Philadelphia PA SCH Dist Go BDS Ser. F 5.00% Due Sep 1, 2027 [GS]sellJoint$50K–$100K22d
Mar 19, 2025Sales Tax Securitization Corp 5.00% Due Jan 1, 2031 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Seattle WA MN LT PW 0% PWR Util Due 05/01/45 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Spring TX Isd 4% Go Utx Due 08/15/31 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Tennessee HSG Dev Agy Residential Fin 2.80% Due Jan 1, 2026 [GS]sellJoint$250K–$500K22d
Mar 19, 2025Triborough Bridge & Tunl 4% SPL Tax Due 11/15/31 [GS]sellJoint$250K–$500K22d
Mar 19, 2025TX Trans Commn TPK 5% TPK Tran Due 08/15/42 [GS]sellJoint$250K–$500K22d
Mar 19, 2025UT ST Tran Auth 5% Excise Tax Due 06/15/36 [GS]sellJoint$100K–$250K22d
Mar 19, 2025Wise CNTY VA Indl Dev Auth Solid Waste 3.80% Due Nov 1, 2040 [GS]sellJoint$100K–$250K22d

Other recent filings by Suzan K. DelBene

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →